TABLE 2 Control Group Specimens, Histologic and Immunohistochemical Diagnosisa

From: In Situ Hybridization and Reverse Transcription–Polymerase Chain Reaction for Cyclin D1 mRNA in the Diagnosis of Mantle Cell Lymphoma in Paraffin-Embedded Tissues

Patient No.

Diagnosis

Tissue

CD23

CD34

TdT

CD5

1

B-CLL

LN

P

N

N

P

2

B-CLL

LN

P

N

N

P

3

B-CLL

LN

P

N

N

P

4

B-CLL

LN

P

N

N

P

5

B-CLL

LN

P

N

N

P

6

B-CLL

LN

P

N

N

P

7

B-CLL

LN

P

N

N

P

8

MZL

LN

P

N

N

N

9

MZL

Spleen

N

N

N

N

10

MZL

Spleen

P/N

N

N

N

11

MALT

LN

N

N

N

N

12

MALT

Gastric

N

N

N

N

13

MALT

Gastric

P/N

N

N

N

14

LBL

LN

N

P

N

N

15

LBL

LN

N

P

P

N

16

LBL

LN

N

P

N

N

17

LBL

LN

N

P

P

N

18

B-CLL

BMB

P/N

N

N

P/N

19

B-CLL

BMB

P/N

N

N

P

20

B-CLL

BMB

N

N

N

P

21

MZL

BMB

N

N

N

N

22

MZL

BMB

N

N

N

N

23

MALT

BMB

N

N

N

N

24

HCL

BMB

N

N

N

N

25

HCL

BMB

N

N

N

N

26

HCL

BMB

N

N

N

N

27

Normal

BMB

N

N

N

N

28

Normal

BMB

N

N

N

N

29

Normal

BMB

N

N

N

N

  1. B-CLL, B-cell chronic lymphocytic leukemia; BMB, bone marrow biopsy; HCL, hairy cell leukemia; LBL, lymphoblastic lymphoma; LN, lymph node; MALT, MALT type lymphoma; MZL, marginal zone lymphoma; N, negative; P, positive.
  2. aThe number of specimens is the same as the number of patients.
Back to article page